Avobenzone: Chemical UVA Filter Research

Last updated August 3, 2026

Carries no SPF rating, because SPF measures only the rays it does not cover.

2/5 protection rating
UVA only
UVB UVA II UVA I

Avobenzone (butyl methoxydibenzoylmethane) is the most common UVA filter in US chemical sunscreens. While effective at absorbing UVA radiation, it suffers from significant photostability issues and demonstrates concerning levels of systemic absorption.

Chemical Properties and UV Protection

Avobenzone, marketed as Parsol 1789, is a dibenzoylmethane derivative that absorbs UVA radiation in the 320-400 nm range. It's the only chemical UVA filter approved in the US at concentrations up to 3%, making it essential for broad-spectrum protection in chemical sunscreens.

UV Absorption Spectrum

Avobenzone provides peak absorption at 357 nm, covering the UVA I range (340-400 nm) that penetrates deep into the dermis. This long-wave UVA protection is critical for preventing photoaging, DNA damage, and melanoma. However, avobenzone provides no UVB protection, requiring combination with other filters.

Photostability Challenges

Rapid Photodegradation

Without stabilizers, avobenzone degrades by 50% after just 1 hour of UV exposure, significantly reducing the sunscreen's effectiveness. This photodegradation occurs through keto-enol tautomerization when exposed to UV light, breaking down the molecule and eliminating its protective capacity.

To address instability, manufacturers combine avobenzone with photostabilizers:

Systemic Absorption Research

FDA Absorption Studies (2019-2020)

FDA clinical trials found avobenzone is absorbed at levels 9 times higher than the agency's safety threshold of 0.5 ng/mL after a single application. Plasma concentrations reached 4.0 ng/mL and remained elevated for days after use stopped.

Key findings from systemic absorption studies:

Safety Concerns

Endocrine Disruption Potential

While less studied than oxybenzone, emerging research suggests avobenzone may have endocrine-disrupting properties. Studies have found it can affect androgen and progesterone receptors, though at lower potency than other chemical filters.

Allergic Reactions

Avobenzone is associated with allergic and photoallergic contact dermatitis. The degradation products formed during photodegradation may be more allergenic than the parent compound, particularly in individuals with sensitive skin.

Environmental Impact

Avobenzone has been detected in surface waters and wastewater treatment plants. While not currently banned like oxybenzone, studies show it can bioaccumulate in aquatic organisms and may contribute to coral bleaching at high concentrations.

Regulatory Status

United States: Approved at up to 3% concentration. FDA has requested additional safety data but has not reached a final determination on GRASE (Generally Recognized As Safe and Effective) status.

European Union: Approved at up to 5% concentration. No current restrictions, though under review for potential endocrine effects.

Other regions: Widely approved globally, though some countries are reviewing safety data in light of absorption studies.

Australia: Permitted under TGA regulation (as butyl methoxydibenzoylmethane). The TGA's 2025 safety review found a margin of safety above 100 and considers it low-risk at permitted levels.

Canada: Permitted under Health Canada's Primary Sunscreen Monograph; avobenzone is the standard UVA filter in Canadian chemical sunscreens, as in the US.

Formulation Considerations

Due to its instability and absorption concerns, avobenzone presents formulation challenges:

  1. Stabilization requirements: Must be combined with photostabilizers, increasing formula complexity
  2. Oil solubility: Requires oil phase or solubilizers in water-based formulas
  3. Incompatibilities: Cannot be formulated with mineral sunscreens (degrades faster)
  4. Concentration limits: 3% maximum limits UVA protection achievable

Products Tested in Scientific Research

Several commercial products containing avobenzone have been tested in peer-reviewed studies:

FDA Absorption Study Products (2019-2020)

Photostability Studies

Combination Product Testing

Alternatives and Recommendations

For those concerned about avobenzone's absorption and stability issues, alternatives include:

Given the systemic absorption data and photostability challenges, individuals may want to minimize avobenzone exposure, particularly with daily use products. When using avobenzone-containing sunscreens, reapplication every 2 hours is essential due to photodegradation.

Our Verdict: 2/5

Avobenzone is essential for UVA protection in US chemical sunscreens but suffers from severe photostability issues and concerning systemic absorption levels that exceed FDA safety thresholds.

Pros

  • Provides critical UVA I protection (340-400 nm range)
  • Only chemical UVA filter approved in the US
  • Effective at 3% concentration when properly stabilized
  • Allows for lightweight, transparent formulations

Cons

  • Degrades by 50% after 1 hour of UV exposure without stabilizers
  • High systemic absorption with blood levels 360x FDA safety threshold
  • Requires additional chemicals like octocrylene for stabilization
  • Associated with allergic reactions and hormone disruption concerns